BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//BioCatalystFeed//bcf//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:BioCatalystFeed OCGN catalysts
X-WR-CALDESC:Scheduling/reference data from public records\; dates can move
 . Not investment\, legal or medical advice.
REFRESH-INTERVAL;VALUE=DURATION:PT12H
X-PUBLISHED-TTL:PT12H
BEGIN:VEVENT
UID:ddf08bfcdc4cb27e6e3d@biocat.ai
DTSTAMP:20261118T181353Z
DTSTART;VALUE=DATE:20270212
DTEND;VALUE=DATE:20270213
SUMMARY:OCGN P3 readout (est.): liMeliGhT
DESCRIPTION:A Phase 3 Study Of OCU400 Gene Therapy for the Treatment Of Ret
 initis Pigmentosa\nNCT06388200 | PHASE3 | ACTIVE_NOT_RECRUITING | sponsor:
  Ocugen\nPrimary completion date (ESTIMATED)\; top-line results usually fo
 llow later.\nTicker OCGN (confidence 0.9)\nSource: https://clinicaltrials.
 gov/study/NCT06388200\nScheduling/reference data from public records\; dat
 es can move. Not investment\, legal or medical advice.
TRANSP:TRANSPARENT
URL:https://clinicaltrials.gov/study/NCT06388200
CATEGORIES:readout,ESTIMATED
END:VEVENT
END:VCALENDAR
